Cargando…
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
Induction or selection of radioresistant cancer (stem) cells following standard radiotherapy is presumably one of the major causes for recurrence of metastatic disease. One possibility to prevent tumor relapse is the application of targeted immunotherapies including, e.g., chimeric antigen receptor...
Autores principales: | Arndt, Claudia, Loureiro, Liliana R., Feldmann, Anja, Jureczek, Justyna, Bergmann, Ralf, Máthé, Domokos, Hegedüs, Nikolett, Berndt, Nicole, Koristka, Stefanie, Mitwasi, Nicola, Fasslrinner, Frederick, Lamprecht, Chris, Kegler, Alexandra, Hoffmann, Anja, Bartsch, Tabea, Köseer, Ayşe Sedef, Egan, Gary, Schmitz, Marc, Hořejší, Vaclav, Krause, Mechthild, Dubrovska, Anna, Bachmann, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219270/ https://www.ncbi.nlm.nih.gov/pubmed/32426176 http://dx.doi.org/10.1080/2162402X.2020.1743036 |
Ejemplares similares
-
Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
por: Mitwasi, Nicola, et al.
Publicado: (2022) -
Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab(®)
por: Jureczek, Justyna, et al.
Publicado: (2020) -
Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers
por: Loureiro, Liliana R., et al.
Publicado: (2020) -
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
por: Mitwasi, Nicola, et al.
Publicado: (2017) -
T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
por: Kegler, Alexandra, et al.
Publicado: (2019)